CIPHER-CORE, Inc
•
Jun 14, 2023 07:00 HKT/SGT
CIPHER-CORE公司(股票代码:CFCI)是一家提供通信系统端到端保护技术、物联网系统远程认证技术和加密现金技术的公司。公司的首席执行官兼总裁中村宇利先生于2023年5月17日至5月19日出席了在墨西哥城举行的数字货币会议(DCC)。来自33个国家的71个组织聚焦于央行和私人数字货币的技术和设计方面。参加这次会议,向与会者介绍了我们产品在数字货币未来方面的成果。会议的第一天,数字货币金融科技创新展示了最杰出的初创金融科技公司、一些创新中心商业银行以及数字货币创新机构。十家创新公司被选中进行项目展示。CIPHER-CORE公司的中村先生是十家入选公司之一,他向央行高管和企业代表介绍了以下内
CIPHER-CORE, Inc
•
Jun 14, 2023 07:00 HKT/SGT
CIPHER-CORE, Inc., (Pink sheets:CFCI) a company that provides end-to-end protection technology for communication systems, remote authentication technology for IoT systems and Crypto Cash technology.Mr. Takatoshi Nakamura, CEO and President attended the Digital Currency Conference (DCC) May 17 throug
ACN Newswire
•
Jun 14, 2023 06:00 HKT/SGT
NSI Lab Solutions is excited to introduce MicroVive(TM), the only 30-day rehydration fluid for freezer storage of microbiological-certified reference materials. MicroVive is a single formulation designed to protect bacterial and fungal cell viability during frozen storage for up to 30 days. It is av
PT Indofood Sukses Makmur Tbk
•
Jun 14, 2023 06:00 HKT/SGT
The 43rd ASEAN Food Security Reserve Board (AFSRB) meeting hosted by Indonesia on June 7-8, 2023, has discussed food security as one of the concerns of Southeast Asian countries since the world is facing the threat of a global food crisis due to climate change, El Nino phenomenon, and geopolitical c

ACN Newswire
•
Jun 13, 2023 22:00 HKT/SGT
Proventus Bioscience, a biotech company that produces sustainable biological microorganisms for use by various industries, announced the start of construction of its new 20,000-square-foot production plant and corporate headquarters at 4455 Griffith St., Saint-Laurent, QC.Proventus' new 20,000-
Pacific Green Technologies Inc.
•
Jun 13, 2023 21:00 HKT/SGT
Pacific Green Technologies, Inc. ("Pacific Green"), (OTCQB:PGTK) announces that it has entered into a sale and purchase agreement ("Agreement") to sell 100% of the shares in Pacific Green Battery Energy Parks 1 Limited ("PGBEP1") to Sosteneo Fund 1 HoldCo S.a.r.l. for G
Pacific Green Technologies Inc.
•
Jun 13, 2023 21:00 HKT/SGT
Pacific Green Technologies, Inc. ("Pacific Green"), (OTCQB:PGTK) announces that it has entered into a sale and purchase agreement ("Agreement") to sell 100% of the shares in Pacific Green Battery Energy Parks 1 Limited ("PGBEP1") to Sosteneo Fund 1 HoldCo S.a.r.l. for G
Quam Plus International Financial Limited
•
Jun 13, 2023 21:00 HKT/SGT
The award presentation ceremony of Quam IR Awards 2022 ('QIRA' or 'The Awards') successfully took place on 12 June, 2023 at Four Seasons Hotel Hong Kong, recognizing investor relations teams that keep pace with the times in a rapidly changing environment, as well as outstanding

Quam Plus International Financial Limited
•
Jun 13, 2023 20:03 HKT/SGT
「华富卓越投资者关系大奖2022」(简称「大奖」)于2023年6月12日假香港四季酒店 (Four Seasons Hotel Hong Kong) 顺利举行,表扬在多变的环境下能与时并进的投资者关系团队,以及具杰出可持续发展管理的优秀企业。嘉许杰出投资者关系工作 【华富卓越投资者关系大奖】致力发掘在投资者关系有出色表现的香港上市公司,得奖企业透过不同途径打开与投资者沟通之门,杰出的专业手腕为投资者关系工作树立了最佳典范,值得表扬。第八届「华富卓越投资者关系大奖」获上市公司热烈支持,本年度共有16家公司获奖,成就非凡。增设两大奖项 表扬低碳绿色管理为肯定机构在实践可持续发展目标上的表现及贡

Quam Plus International Financial Limited
•
Jun 13, 2023 20:02 HKT/SGT
「華富卓越投資者關係大獎2022」(簡稱「大獎」)於2023年6月12日假香港四季酒店 (Four Seasons Hotel Hong Kong) 順利舉行,表揚在多變的環境下能與時並進的投資者關係團隊,以及具傑出可持續發展管理的優秀企業。嘉許傑出投資者關係工作 【華富卓越投資者關係大獎】致力發掘在投資者關係有出色表現的香港上市公司,得獎企業透過不同途徑打開與投資者溝通之門,傑出的專業手腕為投資者關係工作樹立了最佳典範,值得表揚。第八屆「華富卓越投資者關係大獎」獲上市公司熱烈支持,本年度共有16家公司獲獎,成就非凡。增設兩大獎項 表揚低碳綠色管理為肯定機構在實踐可持續發展目標上的表現及貢

HKTDC
•
Jun 13, 2023 18:00 HKT/SGT
The HKTDC Export Index rose 8.8 points to 47.8 in the second quarter this year, showing better business sentiment among Hong Kong exporters after Mainland China's borders reopened and business activities return to normal.All major industries and export markets rallied except for clothing, with

ACN Newswire
•
Jun 13, 2023 15:30 HKT/SGT
Standing at the cusp of numerous digital transitions and technological advancements, Singapore has realized the deep potential of Big Data Analytics (BDA) and AI. The country is witnessing a growing trend among the public & private sector to incorporate these emerging technologies and improve bu

ACN Newswire
•
Jun 13, 2023 12:58 HKT/SGT
The recently concluded Etail- Asia's Premier e-commerce and digital marketing retail summit, hosted by Worldwide Business Research (WBR), held on June 6-8, 2023 exceeded all expectations, attracting industry leaders, visionaries, and retail enthusiasts from around the globe. WBR started the eTa

ACN Newswire
•
Jun 13, 2023 08:00 HKT/SGT
StrikeX is thrilled to announce the successful completion of an investment and strategic partnership with CMC Markets, an award-winning* FTSE 250 financial services provider. CMC Markets has acquired a 33% stake in StrikeX Technologies, with two of its senior executives being welcomed to the StrikeX

ACN Newswire
•
Jun 13, 2023 08:00 HKT/SGT
StrikeX is thrilled to announce the successful completion of an investment and strategic partnership with CMC Markets, an award-winning* FTSE 250 financial services provider. CMC Markets has acquired a 33% stake in StrikeX Technologies, with two of its senior executives being welcomed to the StrikeX

ACN Newswire
•
Jun 12, 2023 22:45 HKT/SGT
Redmatter.Capital, a fully regulated platform for digital assets, today announced the successful deployment of PlatoAi's Ai Powered Web3 Intelligence inside the Redmatter Platform.The result of this successful deployment stemmed from a strategic partnership between the two companies with a coll

SinoMab BioScience Limited
•
Jun 12, 2023 20:45 HKT/SGT
专注研究、发展、制造及商业化免疫性疾病疗法的香港生物制药公司—中国抗体制药有限公司(上市编号:3681.HK,下称“中国抗体”或“本公司”)欣然宣布,SM17(注射用人源化抗IL-17RB单克隆抗体)针对治疗特应性皮炎(AD)的新药研究申请已于6月9日获中国国家药品监督管理局(“国家药监局”)药品审评中心受理。倘若新药研究申请获批,本公司将在中国开展治疗特应性皮炎的临床研发项目。SM17是以白细胞介素17受体B(IL-17RB)为靶点的人源化Ig G4-k单克隆抗体,更是一款针对 IL-17BR 靶点的全球首创单抗药物,具有治疗特应性皮炎、哮喘、特发性肺纤维化及其他免疫性疾病的潜力。 本次新药
SinoMab BioScience Limited
•
Jun 12, 2023 20:44 HKT/SGT
專注研究、發展、製造及商業化免疫性疾病療法的香港生物製藥公司—中國抗體製藥有限公司(上市編號:3681.HK,下稱「中國抗體」或「本公司」)欣然宣佈,SM17(注射用人源化抗IL-17RB單克隆抗體)針對治療特應性皮炎(AD)的新藥研究申請已於6月9日獲中國國家藥品監督管理局(「國家藥監局」)藥品審評中心受理。倘若新藥研究申請獲批,本公司將在中國開展治療特應性皮炎的臨床研發項目。SM17是以白細胞介素17受體B(IL-17RB)為靶點的人源化Ig G4-k單克隆抗體,更是一款針對 IL-17BR 靶點的全球首創單抗藥物,具有治療特應性皮炎、哮喘、特發性肺纖維化及其他免疫性疾病的潛力。 本次新藥
SinoMab BioScience Limited
•
Jun 12, 2023 20:43 HKT/SGT
A Hong Kong-based biopharmaceutical company dedicated to the research, development, manufacturing and commercialization of therapeutics for the treatment of immunological diseases - SinoMab BioScience Limited (Stock Code: 3681.HK, "SinoMab" or the "Company"), is pleased to announ
Doubleview Gold Corp.
•
Jun 12, 2023 20:30 HKT/SGT
Vancouver, British Columbia, June 12, 2023 - (ACN Newswire) - Doubleview Gold Corp. (TSXV: DBG) (OTCQB: DBLVF) (GERMANY: A1W038) (referred to as the "Company" or "Doubleview") is pleased to announce recent progress at its Hat Project. Following the Company's winter program of data compilation and in